Care Pathway Analysis to Inform the Earliest Stages of Technology Development: Scoping Oncological Indications in Need of Innovation

Dec 1, 2023, 00:00
10.1016/j.jval.2023.08.014
https://www.valueinhealthjournal.com/article/S1098-3015(23)03132-7/fulltext
Title : Care Pathway Analysis to Inform the Earliest Stages of Technology Development: Scoping Oncological Indications in Need of Innovation
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03132-7&doi=10.1016/j.jval.2023.08.014
First page : 1744
Section Title : METHODOLOGY
Open access? : Yes
Section Order : 10

Objectives

Identifying unmet needs for innovative solutions across disease contexts is challenging but important for directing funding and research efforts and informing early-stage decisions during the innovation process. Our aim was to study the merits of care pathway analysis to scope disease contexts and guide the development of innovative devices. We used oncologic surgery as a case study, for which many intraoperative imaging techniques are under development.

Methods

Care pathway analysis is a mapping process, which produces graphical maps of clinical pathways using important outcomes and subsequent consequences. We performed care pathway analyses for glioblastoma, breast, bladder, prostate, renal, pancreatic, and oral cavity cancer. Differences between a “perfect” care pathway and the current care pathway in terms of percentage of inadequate margins, associated recurrences, quality of life, and 5-year overall survival were calculated to determine unmet needs. Data from The Netherlands Cancer Registry and literature were used.

Results

Care pathway analysis showed that highest percentages of inadequate margins were found in oral cavity cancer (72.5%), glioblastoma (48.7%), and pancreatic cancer (43.9%). Inadequate margins showed the strongest increase in recurrences in cancer of oral cavity, and bladder (absolute increases of 43.5% and 41.2%, respectively). Impact on survival was largest for bladder and oral cavity cancer with positive margins.

Conclusions

Care pathway analysis provides overviews of current clinical paths in multiple indications. Disease contexts can be compared via effectiveness gaps that show the potential need for innovative solutions. This information can be used as basis for stakeholder involvement processes to prioritize care pathways in need of innovation.

Categories :
  • Methodological & Statistical Research
  • Modeling and simulation
  • Oncology
  • Registries
  • Specialized Treatment Areas
  • Specific Diseases & Conditions
  • Study Approaches
  • Surgery
Tags :
  • care pathway analysis
  • early health technology assessment
  • effectiveness gap
  • imaging technique
  • intraoperative margin assessment
  • responsible innovation
  • technology development
Regions :
  • Western Europe
ViH Article Tags :